ForSight spinoff acquired by QLT Inc.

Forsight Newco II Inc., a privately-held spinoff of ForSight Labs LLC, has agreed to be acquired by QLT Inc. (QLTI) for $42 million as well as future milestone payments and royalties on net sales of products.

The acquisition includes rights to a proprietary ocular punctual plug drug delivery system, which may have potential as a treatment for glaucoma.

ForSight Labs LLC, an ophthalmic technology incubator backed by Menlo Park investment firm Morgenthaler Ventures, Split Rock Partners and Versant Ventures, spun off its first company, Transcend Medical Inc., in late 2006.

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

SF e-scooters burst into flames in Golden Gate Park, ex-contractor reveals

Photographs obtained Wednesday by the San Francisco Examiner show the charred remains of at least two Skip e-scooters

SF politico who authored vape ban takes money from JUUL lobbyist, returns it after media call

Supervisor Shamann Walton made national news after he proverbially smoked e-cigarette company… Continue reading

8 months later, SF has yet to put new conservatorship program into effect

Implementation of SB1045 delayed by need for superior court approval

Stories of political struggle on tap for SF Opera’s 98th season

‘Fidelio,’ ‘Handmaid’s Tale,’ ‘Der Zwerg’ come to War Memorial

Chinatown fixture Yuet Lee prepares for New Year with new leadership in the kitchen

Although Chinese New Year is a holiday, at newly anointed legacy business… Continue reading

Most Read